Skip to main content
Clinical Trials/NCT01862549
NCT01862549CompletedNot Applicable

Adapting Dialectical Behavior Therapy for Children With Disruptive Mood Dysregulation Disorder: Pilot Randomized Clinical Trial

Weill Medical College of Cornell University2 sites in 1 country43 target enrollmentStarted: May 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
43
Locations
2
Primary Endpoint
Psychosocial Treatment Compliance Scale

Study Overview

Brief Summary

This study examines feasibility and preliminary efficacy of Dialectical Behavior Therapy adapted to children (DBT-C). DBT-C as compared to treatment-as-usual (TAU) is hypothesized to have lower drop-out rate, and higher treatment attendance and satisfaction. Further, DBT-C as compared to TAU will have significantly greater reduction in symptoms of Disruptive Mood Dysregulation disorder, including verbal and behavioral outbursts and angry/irritable mood.

Detailed Description

Specific Aims:

I: Conduct Pilot Randomized Clinical Trial to evaluate feasibility and efficacy of DBT for children with Disruptive Mood Dysregulation Disorder (DMDD) as compared with Treatment-As-Usual (TAU) (up to 30 children and caregivers in DBT-C and up to 30 children and caregivers in the treatment as usual comparison condition).

Specific Aim 1: Examine feasibility of DBT-C by evaluating the drop-out rates, number of session attended, and treatment satisfaction and any differences in these rates by groups, as well as therapist treatment adherence and competence.

Hypothesis 1: Attendance rate in DBT-C, as compared to TAU, will be at least 10% higher and drop-out rate will be at least 10% lower (primary feasibility endpoint). Further, DBT-C, as compared with TAU will have significantly higher treatment satisfaction rating by subjects (on the child and caregiver Therapy Satisfaction Questionnaires), and by therapists (on Therapist Satisfaction Scale), and higher patient compliance (on Psychosocial Treatment Compliance Scale). Therapist treatment adherence and competence as measured by DBT-C Treatment Integrity Scale, will not fall below 80%.

Specific Aim 2: Examine preliminary efficacy of DBT-C in reducing symptoms of Disruptive Mood Dysregulation Disorder.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
7 Years to 12 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Ages 7 years 0 months to 12 years 11 months
  • Meet criteria for Disruptive Mood Dysregulation Disorder on DSM-IV
  • Stabilized on psychiatric medication (at least 6 weeks).
  • Able to be treated on the outpatient basis
  • Children with suicidal ideation, suicidal behavior and non-suicidal self-injury will be included (assessed using Columbia Suicide and Self-Injury Severity Rating Scale) unless other interventions are indicated (e.g., hospitalization, medication).

Exclusion Criteria

  • Documented cognitive disability ( if records are not available will use < 85 IQ on Wechsler Intelligence Scale for Children-IV Information and Block Design subtests).
  • Current diagnosis of a psychotic disorder (on K-SADS-PL)
  • Pervasive Developmental Disorder (on K-SADS-PL)
  • Child in the English as Second Language program at school and/or caregivers have language difficulties as per self-report
  • Child is in state custody.
  • As consistent with DMDD diagnosis, child's co-morbid conditions better account for disruptive mood.

Arms & Interventions

Treatment as Usual

Active Comparator

Children in active comparison conditions will receive Treatment as Usual (TAU) that primarily consists of 32 weekly sessions of supportive individual psychotherapy and adjunctive family interventions. Individual therapy included cognitive behavioral skills training (e.g., psychoeducation, cognitive modifications, thought blocking) and non-directive supportive therapy. Family therapy includes parenting skills training (e.g., limit setting, reinforcement techniques), structuring household environment, and safety planning.

Intervention: Treatment as Usual (Behavioral)

DBT for children

Experimental

Dialectical Behavior Therapy for children is a 32 session intervention (it consists of 2 pre-treatment sessions and 30 treatment sessions; treatment sessions are to be delivered in 32 weeks total) with once per week meetings, including 30 min. individual child therapy, 20 min. meeting with a caregiver and 40 min. of skills training with both.

Intervention: Dialectical Behavior Therapy for children (Behavioral)

Outcomes

Primary Outcomes

Psychosocial Treatment Compliance Scale

Time Frame: 32 weeks

Attendance and drop-out rate measure

Time Frame: 32 weeks

Therapy Satisfaction Questionnaire

Time Frame: 32 weeks

Therapist Satisfaction Questionaire

Time Frame: 32 weeks

Secondary Outcomes

  • Measure of Aggression, Violence and Rage in Children(pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up)
  • Emotion Regulation Checklist(pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up)
  • Children Coping Strategies Checklist(pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up)
  • Child Behavior Checklist(pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up)
  • Clinical Global Impression Scale(pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up)
  • Mood Symptoms Questionnnaire(pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up)
  • Affective Reactivity Index(pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up)
  • Columbia Suicide and Self-Injury Serevity Rating Scale(pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up)
  • Social Skills Rating Scale(pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up)
  • Services Assessment Form(pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up)
  • Difficulties in Emotion Regulation Scale(pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up)
  • Parental Response to Children's Negative Emotions Scale(pre-treatment, 8, 16, 24, 32 weeks, 3-month follow-up)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials